Roivant Sciences
ROIV
34.75
-0.78
-2.20%
Roivant Sciences
US · ROIV
#747 by market cap
Listed 1970
34.75
-0.78
-2.20%
Live - 5344 symbols - heartbeat 483s ago
· 2026-10-08 08:13
Pre-market
34.11
-1.84%
After-hours
35.06
+0.91%
Overnight
34.55
-0.58%
- Market cap
- 25.10B
- P/E (TTM)i
- -73.94
- P/Bi
- 5.93
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on ROIV?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
46.56 +34.0%
Price target rangecurrent 34.75
Low40.00
Avg46.56
High55.00
Buy 90%
Hold 10%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | Bernstein | -- | BUY | 41.00 |
| 2026-09-22 | BofA Securities | -- | HOLD | 41.00 |
| 2026-09-17 | Stifel | -- | BUY | 51.00 |
| 2026-09-17 | J.P. Morgan | -- | BUY | -- |
| 2026-09-16 | Stifel | -- | BUY | 51.00 |
| 2026-09-09 | TD Cowen | -- | BUY | 55.00 |
| 2026-09-09 | H.C. Wainwright | -- | BUY | 47.00 |
| 2026-09-08 | TD Cowen | -- | BUY | 55.00 |
| 2026-09-08 | Jefferies | -- | BUY | 52.00 |
| 2026-09-08 | Guggenheim | -- | BUY | 46.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 47.00 |
| 2026-09-01 | J.P. Morgan | -- | BUY | 41.00 |
| 2026-08-28 | Piper Sandler | -- | BUY | 40.00 |
| 2026-08-28 | H.C. Wainwright | -- | BUY | 41.00 |
| 2026-08-10 | Citi | -- | BUY | 46.00 |
| 2026-08-10 | J.P. Morgan | -- | BUY | 40.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 40.00 |
| 2026-08-07 | BofA Securities | -- | HOLD | 37.00 |
| 2026-08-07 | Guggenheim | -- | BUY | 42.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 41.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 50.00 |
| 2026-08-04 | J.P. Morgan | -- | BUY | 40.00 |
| 2026-07-31 | BofA Securities | -- | HOLD | 35.00 |
| 2026-07-24 | Piper Sandler | -- | BUY | 40.00 |
| 2026-06-16 | Piper Sandler | -- | BUY | 40.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q1 | 2026-08-06 | -- | ±10.84% | +1.50% (in line) |
| 2026/Q4 | 2026-05-20 | -- | ±10.94% | +14.89% (beat) |
| 2026/Q3 | 2026-02-06 | -- | ±5.66% | +22.14% (beat) |
| 2026/Q2 | 2025-11-10 | -- | ±8.12% | +2.67% (in line) |
| 2026/Q1 | 2025-08-11 | -- | ±9.71% | -2.79% (in line) |
| 2025/Q4 | 2025-05-29 | -- | ±9.28% | +6.40% (in line) |
| 2025/Q3 | 2025-02-10 | -- | ±8.88% | -0.92% (in line) |
| 2025/Q2 | 2024-11-12 | -- | ±6.81% | -1.44% (in line) |
| 2025/Q1 | 2024-08-08 | -- | ±15.04% | +6.69% (in line) |
| 2024/Q4 | 2024-05-30 | -- | ±10.34% | -3.17% (in line) |
| 2024/Q3 | 2024-02-13 | -- | ±9.13% | -0.64% (in line) |
| 2024/Q1 | 2023-08-14 | -- | ±17.10% | +1.21% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:13:38 · For reference only, not investment advice and not tailored to your situation.